• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽酰精氨酸脱亚氨酶 4 促进骨肉瘤增殖的相关因素。

Factors Associated with Promoted Proliferation of Osteosarcoma by Peptidylarginine Deiminase 4.

机构信息

Department of Oncology, Maternal and Child Health Care Hospital of Zibo, Zibo 255029, China.

Human Resources Department, Zibo Central Hospital, Zibo 255036, China.

出版信息

Biomed Res Int. 2021 May 15;2021:5596014. doi: 10.1155/2021/5596014. eCollection 2021.

DOI:10.1155/2021/5596014
PMID:34055985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8147525/
Abstract

Osteosarcoma is the most common type of bone malignancy, and the pathogenesis has not been entirely elucidated yet. An important deimination modification enzyme PADI4 (peptidylarginine deiminase 4) has attracted much attention in recent years for its important function in several kinds of human tumors. However, the role of PADI4 on osteosarcoma tumorigenesis remains largely unrevealed. Here, we first assessed the effect of PADI4 on osteosarcoma proliferation by the CCK8 method and colony formation assay. Ectopically expressing PADI4 positively regulates the colony formation capacity of both U2OS and Saos-2 cells. Furthermore, we explored the related mechanism and showed that PADI4 could stimulate Wnt/-catenin and MEK/ERK signaling in both U2OS and Saos-2 cells. Then, we detected expression of PADI4 in human tissues of osteosarcoma and revealed that differential expression of PADI4 was associated with tumorigenesis of osteosarcoma. Last, we performed the experiment in nude mice and results also showed PADI4 could affect the tumor growth. In conclusion, this work revealed that PADI4 could upregulate the proliferation of osteosarcoma, mainly via the Wnt/-catenin and MEK/ERK signaling pathway. This study gives us new insight into the regulation mechanism of osteosarcoma proliferation and highlights PADI4 as a promising target for osteosarcoma diagnosis and treatment.

摘要

骨肉瘤是最常见的骨恶性肿瘤,其发病机制尚未完全阐明。近年来,一种重要的脱亚氨基修饰酶 PADI4(肽基精氨酸脱亚氨酶 4)因其在几种人类肿瘤中的重要功能而引起了广泛关注。然而,PADI4 对骨肉瘤肿瘤发生的作用在很大程度上仍未被揭示。在这里,我们首先通过 CCK8 法和集落形成实验评估了 PADI4 对骨肉瘤增殖的影响。过表达 PADI4 可正向调节 U2OS 和 Saos-2 细胞的集落形成能力。此外,我们还探讨了相关机制,并表明 PADI4 可刺激 U2OS 和 Saos-2 细胞中的 Wnt/-catenin 和 MEK/ERK 信号通路。然后,我们检测了 PADI4 在人骨肉瘤组织中的表达,并揭示了 PADI4 的差异表达与骨肉瘤的发生有关。最后,我们在裸鼠中进行了实验,结果也表明 PADI4 可影响肿瘤的生长。总之,这项工作揭示了 PADI4 可上调骨肉瘤的增殖,主要通过 Wnt/-catenin 和 MEK/ERK 信号通路。本研究为骨肉瘤增殖的调控机制提供了新的见解,并突出了 PADI4 作为骨肉瘤诊断和治疗有希望的靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/b50145c31912/BMRI2021-5596014.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/e5cac3dd67ec/BMRI2021-5596014.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/d91db153adec/BMRI2021-5596014.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/295d299ec430/BMRI2021-5596014.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/b50145c31912/BMRI2021-5596014.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/e5cac3dd67ec/BMRI2021-5596014.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/d91db153adec/BMRI2021-5596014.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/295d299ec430/BMRI2021-5596014.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1379/8147525/b50145c31912/BMRI2021-5596014.004.jpg

相似文献

1
Factors Associated with Promoted Proliferation of Osteosarcoma by Peptidylarginine Deiminase 4.肽酰精氨酸脱亚氨酶 4 促进骨肉瘤增殖的相关因素。
Biomed Res Int. 2021 May 15;2021:5596014. doi: 10.1155/2021/5596014. eCollection 2021.
2
PADI4 modulates the invasion and migration of osteosarcoma cells by down-regulation of epithelial-mesenchymal transition.PADI4 通过下调上皮-间充质转化来调节骨肉瘤细胞的侵袭和迁移。
Life Sci. 2020 Sep 1;256:117968. doi: 10.1016/j.lfs.2020.117968. Epub 2020 Jun 13.
3
PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression.PADI4 促进食管鳞癌细胞肿瘤生长并上调 CA9 的表达。
Mol Carcinog. 2019 Jan;58(1):66-75. doi: 10.1002/mc.22907. Epub 2018 Oct 21.
4
Peptidylarginine Deiminase IV Regulates Breast Cancer Stem Cells via a Novel Tumor Cell-Autonomous Suppressor Role.肽基精氨酸脱亚氨酶 IV 通过一种新型肿瘤细胞自主抑制作用调控乳腺癌干细胞。
Cancer Res. 2020 Jun 1;80(11):2125-2137. doi: 10.1158/0008-5472.CAN-19-3018. Epub 2020 Apr 7.
5
URG4 mediates cell proliferation and cell cycle in osteosarcoma via GSK3β/β-catenin/cyclin D1 signaling pathway.URG4 通过 GSK3β/β-catenin/cyclin D1 信号通路介导骨肉瘤中的细胞增殖和细胞周期。
J Orthop Surg Res. 2020 Jun 18;15(1):226. doi: 10.1186/s13018-020-01681-y.
6
Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.沉默 microRNA-27a 通过 SFRP1 依赖性 Wnt/β-catenin 信号通路抑制人骨肉瘤细胞的增殖和侵袭。
Biosci Rep. 2019 Jun 4;39(6). doi: 10.1042/BSR20182366. Print 2019 Jun 28.
7
Endogenous PAD4 in Breast Cancer Cells Mediates Cancer Extracellular Chromatin Network Formation and Promotes Lung Metastasis.乳腺癌细胞内源性 PAD4 介导癌症细胞外染色质网络形成并促进肺转移。
Mol Cancer Res. 2020 May;18(5):735-747. doi: 10.1158/1541-7786.MCR-19-0018. Epub 2020 Mar 19.
8
β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression.β-熊果苷通过内质网(ER)应激介导的 PERK/eIF2α/ATF4/CHOP 激活和 Wnt/β-连环蛋白信号抑制抑制人骨肉瘤的生长。
Phytomedicine. 2020 Apr;69:153183. doi: 10.1016/j.phymed.2020.153183. Epub 2020 Feb 7.
9
Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.高表达的 P2X7 受体通过 PI3K/Akt/GSK3β/β-catenin 和 mTOR/HIF1α/VEGF 信号通路促进人 HOS/MNNG 骨肉瘤细胞的生长和转移。
Int J Cancer. 2019 Aug 15;145(4):1068-1082. doi: 10.1002/ijc.32207. Epub 2019 Mar 18.
10
Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.研究 PADI4 在乳腺癌细胞中的细胞膜定位和抗 PADI4 单克隆抗体的抑制作用。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17253-17268. doi: 10.1007/s00432-023-05433-3. Epub 2023 Oct 7.

引用本文的文献

1
Investigating the cell membrane localization of PADI4 in breast cancer cells and inhibition of anti-PADI4 monoclonal antibody.研究 PADI4 在乳腺癌细胞中的细胞膜定位和抗 PADI4 单克隆抗体的抑制作用。
J Cancer Res Clin Oncol. 2023 Dec;149(19):17253-17268. doi: 10.1007/s00432-023-05433-3. Epub 2023 Oct 7.
2
Role of the PADI family in inflammatory autoimmune diseases and cancers: A systematic review.PADI 家族在炎症性自身免疫性疾病和癌症中的作用:系统评价。
Front Immunol. 2023 Mar 20;14:1115794. doi: 10.3389/fimmu.2023.1115794. eCollection 2023.
3
PAD4 and Its Inhibitors in Cancer Progression and Prognosis.

本文引用的文献

1
The lncRNA-GAS5/miR-221-3p/DKK2 Axis Modulates ABCB1-Mediated Adriamycin Resistance of Breast Cancer via the Wnt/β-Catenin Signaling Pathway.lncRNA-GAS5/miR-221-3p/DKK2轴通过Wnt/β-连环蛋白信号通路调节ABCB1介导的乳腺癌阿霉素耐药性。
Mol Ther Nucleic Acids. 2020 Mar 6;19:1434-1448. doi: 10.1016/j.omtn.2020.01.030. Epub 2020 Feb 1.
2
Evaluation of lumican effects on morphology of invading breast cancer cells, expression of integrins and downstream signaling.评估穹窿蛋白对浸润性乳腺癌细胞形态、整合素表达及其下游信号通路的影响。
FEBS J. 2020 Nov;287(22):4862-4880. doi: 10.1111/febs.15289. Epub 2020 Mar 31.
3
肽基精氨酸脱亚氨酶4(PAD4)及其抑制剂在癌症进展和预后中的作用
Pharmaceutics. 2022 Nov 8;14(11):2414. doi: 10.3390/pharmaceutics14112414.
4
PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.PAD4 依赖性 GSK3β 的瓜氨酸化促进核转位,通过核 CDKNA1 的降解促进结直肠癌的进展。
Neoplasia. 2022 Nov;33:100835. doi: 10.1016/j.neo.2022.100835. Epub 2022 Sep 13.
Withdrawn: Circ-SOX4 promotes non-small cell lung cancer progression by activating the Wnt/β-catenin pathway.
撤稿:环状SOX4通过激活Wnt/β-连环蛋白通路促进非小细胞肺癌进展。
Mol Oncol. 2020 Dec;14(12):3253. doi: 10.1002/1878-0261.12656. Epub 2020 Nov 15.
4
ERK/MAPK signalling pathway and tumorigenesis.ERK/MAPK信号通路与肿瘤发生
Exp Ther Med. 2020 Mar;19(3):1997-2007. doi: 10.3892/etm.2020.8454. Epub 2020 Jan 15.
5
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision Medicine.ERK 抑制剂 LY3214996 针对 ERK 通路驱动的癌症:迈向精准医学的治疗方法。
Mol Cancer Ther. 2020 Feb;19(2):325-336. doi: 10.1158/1535-7163.MCT-19-0183. Epub 2019 Nov 19.
6
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme.肽基精氨酸脱亚氨酶翻译后脱亚精氨酸抑制素并调节多形性胶质母细胞瘤中外泌体释放和 microRNAs。
Int J Mol Sci. 2018 Dec 28;20(1):103. doi: 10.3390/ijms20010103.
7
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum.中性粒细胞促进卵巢癌细胞在大网膜中形成转移前生态位。
J Exp Med. 2019 Jan 7;216(1):176-194. doi: 10.1084/jem.20181170. Epub 2018 Dec 19.
8
PADI4 stimulates esophageal squamous cell carcinoma tumor growth and up-regulates CA9 expression.PADI4 促进食管鳞癌细胞肿瘤生长并上调 CA9 的表达。
Mol Carcinog. 2019 Jan;58(1):66-75. doi: 10.1002/mc.22907. Epub 2018 Oct 21.
9
Osteosarcoma, Chondrosarcoma, and Chordoma.骨肉瘤、软骨肉瘤和脊索瘤。
J Clin Oncol. 2018 Jan 10;36(2):188-193. doi: 10.1200/JCO.2017.75.1743. Epub 2017 Dec 8.
10
Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.骨肉瘤:分子发病机制与诱导多能干细胞建模
Trends Mol Med. 2017 Aug;23(8):737-755. doi: 10.1016/j.molmed.2017.06.004. Epub 2017 Jul 20.